Carbocaine 2% with Neo-Cobefrin Interactions
There are 232 drugs known to interact with Carbocaine 2% with Neo-Cobefrin (levonordefrin/mepivacaine), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 38 are major, 191 are moderate, and 3 are minor.
- View all 232 medications that may interact with Carbocaine 2% with Neo-Cobefrin
- View Carbocaine 2% with Neo-Cobefrin alcohol/food interactions (1)
- View Carbocaine 2% with Neo-Cobefrin disease interactions (2)
Most frequently checked interactions
View interaction reports for Carbocaine 2% with Neo-Cobefrin (levonordefrin / mepivacaine) and the medicines listed below.
- acetylcysteine
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Ambien (zolpidem)
- amitriptyline
- amitriptyline / chlordiazepoxide
- amlodipine
- amoxicillin / clavulanate
- Ativan (lorazepam)
- Atrovent (ipratropium)
- Atrovent Nasal (ipratropium nasal)
- aztreonam
- Bactrim IV (sulfamethoxazole / trimethoprim)
- Basaglar (insulin glargine)
- Benadryl (diphenhydramine)
- Bentyl (dicyclomine)
- calcium / vitamin d
- Cardizem (diltiazem)
- caspofungin
- cefepime
- ceftazidime
- clonazepam
- clonidine
- Compazine (prochlorperazine)
- Creon (pancrelipase)
- Cresemba (isavuconazonium)
- cromolyn
- cyclobenzaprine
- gabapentin
- Zofran (ondansetron)
Carbocaine 2% with Neo-Cobefrin alcohol/food interactions
There is 1 alcohol/food interaction with Carbocaine 2% with Neo-Cobefrin (levonordefrin / mepivacaine).
Carbocaine 2% with Neo-Cobefrin disease interactions
There are 2 disease interactions with Carbocaine 2% with Neo-Cobefrin (levonordefrin / mepivacaine) which include:
Report options
More about Carbocaine 2% with Neo-Cobefrin (levonordefrin / mepivacaine)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
